- $4.28bn
- $3.56bn
- 38
- 26
- 92
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3.02 | 10.3 | 288 | 472 | 720 |
Prepaid Expenses | |||||
Total Current Assets | 3.32 | 10.6 | 291 | 478 | 726 |
Other Long Term Assets | |||||
Total Assets | 3.32 | 10.6 | 294 | 482 | 732 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.35 | 4.38 | 8.79 | 19.5 | 31.8 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 6.52 | 6.62 | 8.79 | 19.5 | 31.8 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -3.21 | 4.03 | 285 | 463 | 701 |
Total Liabilities & Shareholders' Equity | 3.32 | 10.6 | 294 | 482 | 732 |
Total Common Shares Outstanding |